241 related articles for article (PubMed ID: 18523263)
1. T-bet plays a key role in NK-mediated control of melanoma metastatic disease.
Werneck MB; Lugo-Villarino G; Hwang ES; Cantor H; Glimcher LH
J Immunol; 2008 Jun; 180(12):8004-10. PubMed ID: 18523263
[TBL] [Abstract][Full Text] [Related]
2. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection.
van Helden MJ; Goossens S; Daussy C; Mathieu AL; Faure F; Marçais A; Vandamme N; Farla N; Mayol K; Viel S; Degouve S; Debien E; Seuntjens E; Conidi A; Chaix J; Mangeot P; de Bernard S; Buffat L; Haigh JJ; Huylebroeck D; Lambrecht BN; Berx G; Walzer T
J Exp Med; 2015 Nov; 212(12):2015-25. PubMed ID: 26503444
[TBL] [Abstract][Full Text] [Related]
3. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma.
Malaisé M; Rovira J; Renner P; Eggenhofer E; Sabet-Baktach M; Lantow M; Lang SA; Koehl GE; Farkas SA; Loss M; Agha A; Campistol JM; Schlitt HJ; Geissler EK; Kroemer A
J Immunol; 2014 Feb; 192(4):1954-61. PubMed ID: 24415778
[TBL] [Abstract][Full Text] [Related]
4. NK cells inhibit T-bet-deficient, autoreactive Th17 cells.
Wu W; Shi S; Ljunggren HG; Cava AL; Van Kaer L; Shi FD; Liu R
Scand J Immunol; 2012 Dec; 76(6):559-66. PubMed ID: 22928727
[TBL] [Abstract][Full Text] [Related]
5. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner.
Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
7. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.
Zhu Y; Ju S; Chen E; Dai S; Li C; Morel P; Liu L; Zhang X; Lu B
J Immunol; 2010 Sep; 185(6):3174-83. PubMed ID: 20713880
[TBL] [Abstract][Full Text] [Related]
8. In vivo tumor suppression activity by T cell-specific T-bet restoration.
Lee K; Min HJ; Jang EJ; Hong JH; Hwang ES
Int J Cancer; 2010 Nov; 127(9):2129-37. PubMed ID: 20143391
[TBL] [Abstract][Full Text] [Related]
9. Intracellular osteopontin regulates homeostasis and function of natural killer cells.
Leavenworth JW; Verbinnen B; Wang Q; Shen E; Cantor H
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):494-9. PubMed ID: 25550515
[TBL] [Abstract][Full Text] [Related]
10. Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8+ T cells.
Sauer KA; Maxeiner JH; Karwot R; Scholtes P; Lehr HA; Birkenbach M; Blumberg RS; Finotto S
J Immunol; 2008 Nov; 181(9):6148-57. PubMed ID: 18941205
[TBL] [Abstract][Full Text] [Related]
11. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F
J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689
[TBL] [Abstract][Full Text] [Related]
12. Diverse roles for T-bet in the effector responses required for resistance to infection.
Harms Pritchard G; Hall AO; Christian DA; Wagage S; Fang Q; Muallem G; John B; Glatman Zaretsky A; Dunn WG; Perrigoue J; Reiner SL; Hunter CA
J Immunol; 2015 Feb; 194(3):1131-40. PubMed ID: 25556247
[TBL] [Abstract][Full Text] [Related]
13. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet.
Way SS; Wilson CB
J Immunol; 2004 Nov; 173(10):5918-22. PubMed ID: 15528324
[TBL] [Abstract][Full Text] [Related]
16. Monocytes control natural killer cell differentiation to effector phenotypes.
Soderquest K; Powell N; Luci C; van Rooijen N; Hidalgo A; Geissmann F; Walzer T; Lord GM; Martín-Fontecha A
Blood; 2011 Apr; 117(17):4511-8. PubMed ID: 21389319
[TBL] [Abstract][Full Text] [Related]
17. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
18. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
Grundy MA; Zhang T; Sentman CL
Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
[TBL] [Abstract][Full Text] [Related]
19. SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells.
Hu M; Lu Y; Qi Y; Zhang Z; Wang S; Xu Y; Chen F; Tang Y; Chen S; Chen M; Du C; Shen M; Wang F; Su Y; Deng Y; Wang J
Cancer Immunol Res; 2020 Sep; 8(9):1150-1162. PubMed ID: 32561537
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA
Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
